![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » CardioFocus Gains Approval for Excalibur Balloon
CardioFocus Gains Approval for Excalibur Balloon
![Grey Approved Stamp](https://www.fdanews.com/ext/resources/test/Drug-Images4/Grey_Approved_Stamp.gif?t=1576541258&width=430)
May 8, 2018
The FDA granted CardioFocus’ HeartLight Excalibur balloon approval for treating paroxysmal atrial fibrillation (PAF).
The device includes a feature that optimizes the magnitude and speed of target tissue contact during pulmonary vein isolation procedures.
It also incorporates technology that allows the user to make real-time adjustments to balloon size to facilitate optimal tissue contact.
Upcoming Events
-
21Oct